JSPRJasper Therapeutics, Inc.

JSPR Stock Price, Valuation & Chart | Jasper Therapeutics, Inc.

Compare

$0.700+0.01 (+1.05%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology JSPR intrinsic value JSPR calculated fair value vs price

Overview Financials Dividends Ratios

JSPR Historical price chart

JSPR Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization11.46M

PE Ratio-0.22

EPS-3.25

Trading Volume380.27K

Today's High/Low0.72/0.68

Dividend Yield0.00

52 Week High/Low2.83/0.32

Shares Outstanding16.25M

JSPR Financial Statement

JSPR Analyst ratings

JSPR Analysis & performance metrics

JSPR Company profile

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on…

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells…

JSPR Management team

Name

Position

Wendy Pang M.D., Ph.D.

Senior Vice President of Research & Translational Medicine

Kimberly Baxter

Vice President & Head of Quality

Jeetinder Singh Mahal M.B.A.COO

Chief Operating Officer

Edwin Jonathan Tucker M.D.

Chief Medical Officer

Ronald A. MartellCEO

President, Chief Executive Officer & Director

Judith Anne Shizuru M.D., Ph.D.CTO

Co-Founder, Member of Scientific Advisory Board & Director

Matthew Ford

Senior Vice President of Human Resources

Patricia Carlos

Senior Vice President of Regulatory Affairs & Quality

Name

Position

Wendy Pang M.D., Ph.D.

Senior Vice President of Research & Translational Medicine

Kimberly Baxter

Vice President & Head of Quality

Jeetinder Singh Mahal M.B.A.COO

Chief Operating Officer

Edwin Jonathan Tucker M.D.

Chief Medical Officer

Ronald A. MartellCEO

President, Chief Executive Officer & Director

Judith Anne Shizuru M.D., Ph.D.CTO

Co-Founder, Member of Scientific Advisory Board & Director

Matthew Ford

Senior Vice President of Human Resources

Patricia Carlos

Senior Vice President of Regulatory Affairs & Quality

Management Team

Wendy Pang M.D., Ph.D.

Senior Vice President of Research & Translational Medicine

Kimberly Baxter

Vice President & Head of Quality

Jeetinder Singh Mahal M.B.A.COO

Chief Operating Officer

Edwin Jonathan Tucker M.D.

Chief Medical Officer

Ronald A. MartellCEO

President, Chief Executive Officer & Director

Judith Anne Shizuru M.D., Ph.D.CTO

Co-Founder, Member of Scientific Advisory Board & Director

Matthew Ford

Senior Vice President of Human Resources

Patricia Carlos

Senior Vice President of Regulatory Affairs & Quality

Management

Wendy Pang M.D., Ph.D.

Senior Vice President of Research & Translational Medicine

Kimberly Baxter

Vice President & Head of Quality

Jeetinder Singh Mahal M.B.A.COO

Chief Operating Officer

Edwin Jonathan Tucker M.D.

Chief Medical Officer

Ronald A. MartellCEO

President, Chief Executive Officer & Director

Judith Anne Shizuru M.D., Ph.D.CTO

Co-Founder, Member of Scientific Advisory Board & Director

Matthew Ford

Senior Vice President of Human Resources

Patricia Carlos

Senior Vice President of Regulatory Affairs & Quality

Total 8 executives

JSPR Frequently asked questions

What is Jasper Therapeutics, Inc. (JSPR) Stock Price?

Current stock price of Jasper Therapeutics, Inc. (JSPR) stock is $0.700. The stock price is +1.05% higher in the session. The intraday range can be seen from this page. Volume of Jasper Therapeutics, Inc. (JSPR) stock is 380.27K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Jasper Therapeutics, Inc. (JSPR) stock price going up or down today?

The stock price of Jasper Therapeutics, Inc. (JSPR) can change with earnings, company news, and overall market sentiment. Jasper Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Jasper Therapeutics, Inc. stock expensive at its current price?

Whether Jasper Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for JSPR on this page is -0.22. EPS on this page is -3.25. Compare those figures with peers and growth expectations before deciding if the current Jasper Therapeutics, Inc. price is justified.

How has the stock price of Jasper Therapeutics, Inc. (JSPR) performed historically?

Historical performance for Jasper Therapeutics, Inc. (JSPR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how JSPR reacted to past earnings and market events.

Should I buy Jasper Therapeutics, Inc. (JSPR) stock, at this price?

Buying Jasper Therapeutics, Inc. (JSPR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.